These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1334543)

  • 1. [Treatment of dysimmune neuropathies with intravenous polyvalent human immunoglobulins].
    Leger JM; Hoang-Xuan K; Chennoufi A; Saidi H; Bouche P; Baumann N; Brunet P
    Presse Med; 1992 Oct; 21(32):1533. PubMed ID: 1334543
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulins in the treatment of immune neuropathies.
    Kieseier BC; Meyer Zu Hörste G; Lehmann HC; Gold R; Hartung HP
    Curr Opin Neurol; 2008 Oct; 21(5):555-62. PubMed ID: 18769249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
    Nobile-Orazio E; Bersano A
    Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of certain immune deficient peripheral neuropathies with intravenous immunoglobulins].
    Pouget J
    Rev Prat; 1994 Nov; 44(18):2404-6. PubMed ID: 7855497
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of peripheral neuropathies associated with IgM anti-myelin monoclonal gammopathy].
    Mariette X; Oksenhendler E
    Rev Neurol (Paris); 1996 May; 152(5):413-6. PubMed ID: 8881442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraproteinemic neuropathies.
    Rojas-García R; Gallardo E; Illa I
    Presse Med; 2013 Jun; 42(6 Pt 2):e225-34. PubMed ID: 23618626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and treatment of patients with neuropathy and monoclonal gammopathy.
    Latov N
    Semin Neurol; 1994 Jun; 14(2):118-22. PubMed ID: 7984826
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma exchange in immune-mediated neuropathies.
    Lehmann HC; Hartung HP; Meyer Zu Hörste G; Kieseier BC
    Curr Opin Neurol; 2008 Oct; 21(5):547-54. PubMed ID: 18769248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuropathies associated with monoclonal IgM anti-MAG antibodies].
    Pihan M; Decaux O; Marcorelles P; Bahon-Riedinger I; Lemercier S; Gainche-Salmon A; Doncker AV
    Rev Med Interne; 2012 Dec; 33(12):686-92. PubMed ID: 22726239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune mediated neuropathies--an update on therapeutic strategies.
    Czaplinski A; Steck AJ
    J Neurol; 2004 Feb; 251(2):127-37. PubMed ID: 14991345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraproteinemic neuropathy: a practical review.
    Rison RA; Beydoun SR
    BMC Neurol; 2016 Jan; 16():13. PubMed ID: 26821540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic and quality of life evaluation of different modalities of immunoglobulin therapy in chronic dysimmune neuropathies.
    Cocito D; Serra G; Paolasso I; Barilà DA; Lopiano L; Cattel L
    J Peripher Nerv Syst; 2012 Dec; 17(4):426-8. PubMed ID: 23279347
    [No Abstract]   [Full Text] [Related]  

  • 14. Peripheral nervous system neuroimmunology seen by a neuro-pathologist.
    Vallat JM
    Rev Neurol (Paris); 2014 Oct; 170(10):564-9. PubMed ID: 25200480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraproteinemic neuropathies.
    Raheja D; Specht C; Simmons Z
    Muscle Nerve; 2015 Jan; 51(1):1-13. PubMed ID: 25288371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic approach in peripheral neuropathies].
    Léger JM
    Rev Prat; 1992 Jan; 42(1):46-50. PubMed ID: 1314414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon beta normalizes suppressor cell function in dysimmune neuropathies.
    De Luca G; Lugaresi A; Iarlori C; Marzoli F; Uncini A; Gambi D
    J Neuroimmunol; 1998 Feb; 82(1):1-4. PubMed ID: 9526839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Paraproteinemic neuropathies: foundations for a specific therapy related to patients' quality of life].
    Casadevall Codina T; Pérez Lázaro C; Santos S; Fabre Pi O; Garcés Redondo M; Larrodé Pellicer P
    Rev Neurol; 2004 Apr 1-15; 38(7):631-6. PubMed ID: 15098183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dysimmune neuropathies: current diagnosis and therapy].
    Léger JM; Larue S; Dashi F
    Rev Prat; 2008 Nov; 58(17):1887-9, 1892-4. PubMed ID: 19157204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of peripheral neuropathies.
    Hallett M; Tandon D; Berardelli A
    J Neurol Neurosurg Psychiatry; 1985 Dec; 48(12):1193-207. PubMed ID: 3003254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.